Chang Moo Jeon acquired 8.5% stake in U2Bio CO. LTD. (XKON:A221800) from MAC Fund, L.P. (Class B), a fund managed by M-Venture Investment, Inc. (KOSDAQ:A019590) for KRW 1.6 billion on September 18, 2020. Under the terms, Chang Moo Jeon acquired 0.14 million shares at a price of KRW 10,000 per share.

Chang Moo Jeon completed the acquisition of 8.5% stake in U2Bio CO. LTD. (XKON:A221800) from MAC Fund, L.P. (Class B), a fund managed by M-Venture Investment, Inc. (KOSDAQ:A019590) on September 18, 2020.